Medically reviewed by Archana Sharma, DO Key Takeaways Colon cancer treatment depends on the stage, tumor characteristics, ...

Diagnostic and surgical approaches to treating the disease are evolving — just as rates are spiking. Learn how the surgical ...

Ciara Mageean, the Irish runner who won the European 1,500-meter title in Rome, died on November 1 at age 34. She had been ...

The approach only works for a specific genetic subtype of bowel cancer, and the researchers now say they can predict who it works for.

An 85-year-old woman with a positive Cologuard test seeks guidance after her gastroenterologist declined a colonoscopy.

In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic ...

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world ...

High-dose omega-3 fatty acid supplements might improve survival among some patients with advanced colon cancer, a new study ...

In the phase 3 EMT2 trial, high-dose EPA was associated with longer overall survival but not improved progression-free ...

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for ...

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific ...

An 85-year-old woman with a positive Cologuard test seeks guidance after her gastroenterologist declined a colonoscopy, ...